Stockreport

BioSig to Host Conference Call on Recent Developments of Subsidiary ViralClear and its Broad-Spectrum Oral Anti-Viral Candidate Merimepodib for the Treatment of COVID-19

BioSig Technologies, Inc.  (BSGM) 
NASDAQ:AMEX Investor Relations: biosigtech.com
PDF Westport, CT, April 24, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) today announced that it will be hosting an invest [Read more]